Is the frequency of carisoprodol withdrawal syndrome increasing?

Pharmacotherapy

Volumn 27, Issue 10, 2007, Pages 1462-1466

  Reeves, Roy R ^a,b   Hammer, Jeffrey S ^c   Pendarvis, Richard O ^d  

^a G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c Department of Psychiatry   (United States)

^d Diagnostic Medical Sonography Technology Program   (United States)

Author keywords

Carisoprodol; Carisoprodol withdrawal syndrome; Drug abuse; Meprobamate; Substance abuse; Withdrawal

Indexed keywords

CARISOPRODOL; LORAZEPAM; OXYCODONE; RISPERIDONE;

ADULT; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; DETOXIFICATION; DRUG ABUSE; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG METABOLISM; FEMALE; HUMAN; MALE; VISUAL HALLUCINATION; WITHDRAWAL SYNDROME;

ADULT; ANXIETY; CARISOPRODOL; FEMALE; HALLUCINATIONS; HUMANS; MEPROBAMATE; MUSCLE RELAXANTS, CENTRAL; SELF ADMINISTRATION; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; TABLETS;

EID: 34948889332     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.10.1462     Document Type: Article

References (31)

1. Moore RM, Chua L. Carisoprodol dependence: a case report. Am J Drug Alcohol Abuse 1978;5:527-30.
2. Elder NC. Abuse of skeletal muscle relaxants. Am Fam Physician 1991;44:1223-6.
3. Rust GS, Hatch R, Gums JG. Carisoprodol as a drug of abuse. Arch Fam Med 1993;2:429-32.
4. Sikdar S, Basu D, Malhotra AK, Varma VK, Mattoo SK. Carisoprodol abuse: a report from India. Acta Psychiatr Scand 1993;88:302-3.
5. Luehr JG, Meyerle KA, Larson EW. Mail-order (veterinary) drug dependence [letter]. JAMA 1990;263:657.
6. Littrell RA, Sage T, Miller W. Meprobamate dependence secondary to carisoprodol (Soma) use. Am J Drug Alcohol Abuse 1993;19:133-4.
7. Reeves RR, Pinkofsky HB, Carter OS. Carisoprodol: a drug of continuing abuse. J Am Osteopathic Assoc 1997;97:723-4.
8. Reeves RR, Carter OS, Pinkofsky HB. Use of carisoprodol by substance abusers to modify the effects of illicit drugs [letter]. South Med J 1999;92:441.
9. Reeves RR, Liberto V. Abuse of combinations of carisoprodol and tramadol. South Med J 2001;94:512-14.
10. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Emergency department trends from the Drug Abuse Warning Network, final estimates 1994-2001. DAWN series D-21. DHHS publication no. (SMA) 02-3635. Rockville, MD; 2002. Available from www.oas.samhsa.gov/DAWN/final2k1EDtrends/text/ EDtrend2001v6.pdf. Accessed May 8, 2007.
11. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network, 2005: national estimates of drug-related emergency department visits. DAWN series D-29. DHHS publication no. (SMA) 07-4256. Rockville, MD; 2007. Available from dawninfo.samhsa.gov/files/DAWN2k5ED.htm. Accessed May 8, 2007.
12. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National survey on drug use and health home page. Available from www.oas.samhsa.gov/nsduh.htm. Accessed May 8, 2007.
13. Reeves RR, Beddingfield JJ, Mack JE. Carisoprodol withdrawal syndrome. Pharmacotherapy 2004;24:1804-6.
14. Rohatgi G, Rissmiller DJ, Gorman JM. Treatment of carisoprodol dependence: a case report. J Psychiatric Pract 2005;11:347-52.
15. Bramness JG, Skurtveit S, Morland J. Impairment due to intake of carisoprodol. Drug Alcohol Depend 2004;74:311-18.
16. Littrell RA, Hayes LR, Stillner V. Carisoprodol (Soma): a new and cautious perspective on an old agent. South Med J 1993;86:753-6.
17. Meyer MC, Straughn A. Meprobamate. J Am Pharm Assoc 1977;17:173-5.
18. Del Castilo J, Nelson TE Jr. The mode of action of carisoprodol. Ann NY Acad Sci 1960;86:108-42.
19. Bailey DN, Briggs JR. Carisoprodol: an unrecognized drug of abuse. Clin Chemistry 2002;117:396-400.
20. Reeves RR, Carter OS, Pinkofsky HB, Struve FA, Bennett DM. Carisoprodol (Soma): abuse potential and physician unawareness. J Addict Dis 1999;18:51-6.
21. Roache JD, Griffith RR. Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability. J Pharmacol Exp Ther 1987;243:978-88.
22. Anonymous. Physicians' desk reference, 59th ed. Montvale, NJ: Thompson Healthcare; 2005:1976.
23. Wyller TB, Korsmo G, Gadeholt G. Dependence on carisoprodol (Somadril)? A prospective study among prisoners [in Norwegian]. Tidsskrifft Den Norske Laegeforening 1991;111:193-5.
24. Reeves RR, Parker JD. Somatic dysfunction during carisoprodol cessation: evidence for a carisoprodol withdrawal syndrome. J Am Osteopathic Assoc 2003;103:75-80.
25. Haizlip TM, Ewing JA. Meprobamate habituation: a controlled clinical study. N Engl J Med 1958;258:1181-6.
26. Olson H, Koppang E, Alvan G, Morland J. Carisoprodol elimination in humans. Ther Drug Monit 1994;16:337-40.
27. Stead AH, Moffat AC. A collection of therapeutic, toxic, and fatal blood drug concentrations in man. Hum Toxicol 1983;2:437-64.
28. Davis GG, Alexander CB. A review of carisoprodol deaths in Jefferson County, Alabama. South Med J 1998;91:726-30.
29. Kentucky Board of Medical Licensure. Clarification of Nubain and Soma. Kentucky Board Med Licensure Newsl 2005 Fall; 3. Available from http://www.kbml.ky.gov/NR/rdonlyres/E18F5950-AC0F-4364-AB56-C9335D714645/0/ fall2005.pdf.
30. Arizona State Board of Pharmacy. Carisoprodol scheduled as a controlled substance effective September 19, 2003. Arizona State Board of Pharmacy newsletter, October 2003;24:1. Available from www.azpharmacy.gov/pdfs/ 1003AZNWSLTR.pdf. Accessed July 17, 2007.
31. Florida Legislature. Title XLVI: crimes. Chapter 893.03: drug abuse prevention and control (2002). Crime prevention, corrections & safety: final analysis. HB 351 (passed as SB 612) relating to controlled substances/carisoprodol. Available from www.leg.state.fl.us/data/session/2002/ House/bills/analysis/pdf/2002h0351z.cpcs.pdf. Accessed May 6, 2007.